Armata Pharmaceuticals, Inc. (ARMP) Misses Q1 EPS by 52c

Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q1 EPS of ($0.69), $0.52 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $970 thousand versus the consensus estimate of $1 million.

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.

You May Also Be Interested In

• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• X Financial (XYF) Tops Q2 EPS by 438c
• Scinai posts H1 2026 results with wider operating loss, net gain